Connect with us

Maine

Why overdose deaths are declining in Maine

Published

on

Why overdose deaths are declining in Maine


Maine is set to close out 2024 as a year that saw a continued decline in drug overdose deaths. But while the top official responsible for coordinating the state’s response to the opioid crisis is glad to see the trend, he’s not celebrating.

That’s because the approximately 500 total overdose deaths projected for this year is still far too high, Gordon Smith, Maine’s director of opioid response, said in an interview.

“One death is too many, but 500 is a catastrophe. It’s simply better than 720 [in 2022],” he said, referring to the year when Maine saw its greatest number of overdose deaths.

Across Maine, 405 people died after overdosing between January and October, according to the Maine Drug Data Hub. That official count represents a 20 percent decrease compared with the same time period in 2023. It continues the decline first seen in 2023, when fatal overdoses decreased 16 percent compared with 2022.

Advertisement

The reasons for the decline are not truly known, Smith said, but it is probably at least partially due to the decreasing potency of fentanyl, a powerful manmade opioid that is the most frequent cause of death. There are also more services in Maine to help people with an addiction to opioids than in the past.

The Bangor Daily News spoke with Smith about the changes he has seen since his position in state government was created in 2019, after fentanyl turned Maine’s ongoing opioid crisis even more deadly. From distributing hundreds of thousands of doses of overdose-reversing naloxone, to training more than 2,000 people as peer recovery coaches, to expanding access to treatment, Maine has significantly boosted help for people who need it, Smith said.

For instance, more than 5,000 people are currently receiving methadone, the most ever, Smith said. Providers in Maine are also prescribing a record 16,000 to 20,000 people with buprenorphine, another medication for opioid use disorder. While people can have success with an abstinence-based approach to treatment, he said, medications such as methadone and buprenorphine have been shown to increase people’s odds of staying in long-term recovery.

The following Q&A has been condensed:

Gordon Smith, state of Maine: I think one of the reasons that this is all going better now is that so many people are willing to take some help medically, and we’ve really encouraged the medical community to step up and make that available in all the primary care practices, in all the emergency departments — low-barrier access to buprenorphine. We’re only down to three to five [predominantly small, rural] emergency departments in Maine that aren’t ready to do that, and we’re working with them to make sure that they do get ready to do it.

Advertisement

Erin Rhoda, BDN: I don’t know that any ERs a number of years ago were prescribing buprenorphine. Is that right?

Smith: None were.

You’re recalling, in Executive Order 2, which established my position in February of 2019 … we said the first thing I’m going to do is buy 35,000 doses of naloxone. … Now it’s truly the thing that’s making the biggest difference in keeping people alive. The data in [the state’s monthly overdose report] is startling: 95 percent of people that overdose in Maine today are surviving their overdose. That’s remarkable. …

The second thing we said in that executive order, after we purchased 35,000 doses of naloxone, was we were going to ask every emergency department to have low-barrier access available to buprenorphine, to any patient that came in after an overdose or was otherwise struggling with substances. …

One of my favorite things in that executive order was we asked every prison and facility and every jail to make sure that people who had a substance use disorder were treated for their illness and had medication available, meaning buprenorphine generally.

Advertisement

Because it’s just stunning, as a health care lawyer, that in 2019, two decades after the Americans with Disabilities Act, that people with substance use disorder were not treated when they were incarcerated. And that’s still true in the majority of carceral settings in this country. …

Almost 50 percent of the [inmates in Maine’s prison system] are on medication for substance use disorder. Which sounds like an insane amount except we know that 70 or 80 percent of them have a substance use disorder. In many of the jails also the numbers are up around 50 percent, sometimes more.

Rhoda: Are all jails now offering treatment?

Smith: They’re all offering treatment. They’re all offering medication. They’re not necessarily all offering the injectable version of buprenorphine. The goal would be to offer all [U.S. Food and Drug Administration] approved products for substance use disorder and in all of their versions — injectable, film, pills, whichever works for that particular resident of the jail, but almost no jail or facility at this point is able to offer all those versions.

Rhoda: [The jails offering medication] seems like a huge change.

Advertisement

Smith: There’s not a single facility, Erin, that is where we’d like to have them right now, but they’re all way, way better than it was. The reason that they’re not further along is really resources. … We’ve made some more state money available to them. The governor did $4 million in the last budget, more money for the jails for these purposes, but it really is an issue of resources.

And you know, in the grand scheme of things I’d really prefer to not see people with substance use disorder in jail. I’d like to see a lot more diversion. …. The treatment courts are trucking along. We’ve got one in … every county except Aroostook County, and we’ve got a great plan up there that Todd Collins, [the district attorney], and a whole bunch of people worked on, but we need $750,000 a year to do it, and nobody has come up with that money. So we’ll try again.

Rhoda: I also remember when there were no detox beds [at facilities that medically supervise people through the acute stages of withdrawal].

Smith: We now have about 120, 130 detox beds because we’ve also been successful in getting the private places to open some beds to MaineCare, like Pine Tree in Portland and Libby Bay. We’ve got 10 beautiful Wabanaki beds [in Bangor] … but they’re not full. I think part of it is communicating to people who might need those beds that they’re not just for Indigenous Mainers, number one, and that they’re open for business.

Rhoda: When it comes to the overdose death rates, are you seeing really big declines in certain areas? Where in Maine have you seen the biggest declines?

Advertisement

Smith: Actually in Portland. It has not been uniform across the state. There are some counties that will see more deaths this year than last year. They tend to be smaller numbers, but still. …

We’ve seen the biggest decline really in the urban areas, and we’ve not done as well in reducing overdoses in some of the rural areas. We need to do a better job there. Some of it is hard to address. It takes a long time to get an ambulance out to Springfield, Maine, 20 miles east of Lincoln, right? Fentanyl acts very quickly. Too many people use alone. Why do they use alone? There’s a lot of shame and stigma associated with it.

Rhoda: Stimulants are continuing to increase as a cause of death in combination with other drugs like fentanyl. What do you make of that, why that’s happening?

Smith: I don’t think anybody knows. Not a week goes by that we’re not on some webinar with our federal partners and national people; we get together with our New England group all the time, we talk about these things. Nobody really knows. People don’t even know why the death rate is declining. We speculate.

There’s a North Carolina drug lab run by Dr. [Nabarun] Dasgupta. He posited eight different theories [for the decline in overdose deaths]. They all made sense to me: more naloxone, more treatment available. …

Advertisement

Now xylazine [a sedative added to fentanyl that is not as lethal] is a factor. We’re up to 14 to 16 percent xylazine. Oddly enough it might be some of these fillers that are helping to keep people alive. It’s still doing really bad things to them, you know, but they don’t die.

Rhoda: With xylazine, that’s a relatively new thing. Do you think that that filler is playing a role in the declining number of deaths?

Smith: It is one of the things that the researchers are speculating that may be part of why fewer people are dying. …

The fact is that nationwide we’ve seen a 10 to 12 percent decline, and not every state is doing what we’re doing, right? In some of the New England states, probably New Hampshire and Maine have seen the sharpest declines. But every state has seen some improvement. So it’s more than just what we’re doing.

Rhoda: Where does Maine stand exactly in its decrease of opioid deaths relative to the nation? We are falling faster?

Advertisement

Smith: Yes, but we were also higher to start with. We started from a pretty bad place in 2018, 2019. And so we’re coming down now towards the middle.

Rhoda: I’ve been reading about the declining toxicity of fentanyl. The fentanyl on the street is becoming weaker. Is that happening in Maine?

Smith: Probably. We don’t necessarily have enough drug checking and drug testing to know that. … It’s funny because we used to talk about fentanyl adultering everything else; now people want fentanyl, and it’s being adulterated with everything from xylazine to other fillers, including cocaine and meth.

So, again, we don’t have the sophisticated kind of drug-checking apparatus. We’ve got four new drug-checking machines that are just starting to be used. There’s one in Machias, one in Sanford, as part of Project DHARMA. It’s a federal grant run out of the Maine Medical Center. …

The whole idea is we’re going to start testing residual amounts of drugs — in syringes usually — at various sites around the state and then get that to the Colby drug lab and see what’s in these drugs. That will give us maybe a head start on what kind of drug policies we need in the state in reaction to that. So it’s possible in a year or two when you ask me the question about the strength of the fentanyl that I’d have actually good chemistry to answer that question, but it’s just starting.

Advertisement

Rhoda: What do you think next year will bring?

Smith: I don’t think we need a lot of new initiatives, but I think we need to put more resources into all the things we’re doing. We had one crisis receiving center [to help people with a range of mental health or substance use challenges]. Now we’re going to have five. We had three McAulay houses [for women in recovery and their children]. Now we’re going to have seven. We’ve got 1,000 recovery beds [at about 100 recovery residences]. We need probably 200 more in rural areas.

We need to just keep doing what we’re doing, lower the stigma, let people know we care about them, give them hope, and make sure when they’re ready today that we’ve got a bed for them, or an outpatient facility, whatever they need. That’s my hope.

Rhoda: A final note here: What do you want families to do if they have a loved one with addiction? If they’re reading this and they think, I really need to do something, what is your advice?

Smith: There are support groups for family members. We have 24 recovery community centers now. Call 211. Don’t suffer in silence alone, and don’t give up on your loved one.

Advertisement

Erin Rhoda is the editor of Maine Focus and may be reached at erhoda@bangordailynews.com.



Source link

Maine

Maine’s Susan Collins-Graham Platner race expected to draw nearly $400M in ads

Published

on

Maine’s Susan Collins-Graham Platner race expected to draw nearly 0M in ads


When BDN shines a light, policymakers act. Make a gift to help our reporters keep Maine’s leaders informed. Make a donation now. 

More than $200 million was spent in Maine’s U.S. Senate race in 2020, a historic figure that raised eyebrows and became a case study for advocates of campaign finance reform.

Six years later, as Democrats bank on progressive Graham Platner and Republicans look to defend five-term U.S. Sen. Susan Collins to keep hold of the Senate, that record is about to be obliterated in political advertising alone.

Overall ad spending in Maine this election cycle could reach almost $500 million, according to the latest projection from AdImpact. The amount is driven by a whopping new estimate of $384 million in the Collins-Platner race alone, making the contest the fourth-most expensive Senate race in the country behind Texas, Michigan and Georgia. The races for the 2nd Congressional District and governor could also see heavy spending.

Advertisement

The new estimate nearly doubles what AdImpact previously expected in Maine’s Senate race. It comes after contentious primary season spending and after Platner weathered a string of controversies in the fall and recent weeks to secure the Democratic nomination.

More than $150 million in ads through Election Day have already been booked in the race, about $100 million of it by Collins-aligned groups. But Democrats — who outspent Republicans in former Maine House Speaker Sara Gideon’s losing bid in 2020 — are sure to catch up as they push to take back Congress from President Donald Trump’s Republican Party.

“From record-setting races and surging party committee war chests to a competitive landscape that continues to expand, all indicators point to 2026 being the most expensive political advertising cycle in history,” AdImpact said in its report.

Nationwide, AdImpact expects $11.6 billion in ad spending this year, up from the 2023-2024 cycle’s record $11.2 billion. Political spending has exploded nationwide since the U.S. Supreme Court’s 2010 decision in Citizens United v Federal Election Commission.

Ads are also increasingly costly in Maine. A candidate’s 30-second spot in Portland cost an average of almost $250 in 2020, compared with $314 this year. But the rate for a 30-second ad from an issue group has nearly doubled, at almost $945 compared to $490 in 2020, according to AdImpact. Stations must give candidates priority and their lowest rates.

Advertisement

Month-by-month averages have fluctuated this year, but issue groups that have dominated the airwaves have seen costs rise each of the last three months, with the current average for 30 seconds of airtime almost $1,600.

Running on a message of overhauling the power structure in Washington, Platner has proven a solid fundraiser who effectively booted Gov. Janet Mills from the Senate race. Collins and her allies have offered ads touting the senator’s track record of bringing home federal investment and others targeting Platner’s background, from a Nazi-linked tattoo he’s since covered to offensive social media comments and alleged toxic behavior in past relationships.

Platner outraised Collins between January of last year and May, about $16 million to more than $12 million. Platner has almost $350,000 in ads booked from the day after he won the primary through Election Day. Platner’s bid has received a boost of almost $11 million combined in ads going after Collins from the nonprofit dark money groups Majority Forward, Unrig Our Economy and Duty and Honor.

The Collins campaign hasn’t booked nearly as many ads yet between this week and Election Day. But she has significant help from dark money political action committees such as One Nation and Pine Tree Results PAC, which have already been running ads and have booked more than $46 million million combined so far.

Pine Tree Results has seen at least $1 million in donations from the Lexington Fund-connected Republican legal activist Leonard Leo, and $2.5 million from Florida hedge fund billionaire Ken Griffin. Nearly 100 billionaires and their spouses have donated almost $10 million collectively to Collins’ network since the beginning of last year, The Maine Monitor reported.

Advertisement

The Winning for Women Action Fund, a super PAC boosting Republican women, has booked $16 million in pro-Collins ads. Her campaign has also received more than $538,000 from at least 315 individual donors bundled through AIPAC, the pro-Israel lobbying group.

Collins’ campaign and allies make the case that Platner will likely pick up just as much if not more super PAC and dark money donations, including from billionaires. They also say while some wealthy donors give based on ideology, many are more focused on stable government, leading them to embrace the longtime lawmaker and chair of the Senate Appropriations Committee.

Platner has rallied progressives around the argument that the money flowing into politics leads to votes that too often help donors, not working Mainers. His campaign on Friday pointed to his endorsement in May by the anti-corruption group End Citizens United, which accuses Collins of never meeting “a corporate PAC check she didn’t like.”

“We’re building a movement to get money out of politics and build a government that represents working people, not billionaires,” Platner said at the time.

American Promise, a Massachusetts-based nonprofit pressing for a constitutional amendment to empower states and Congress to regulate campaign fundraising and spending, has made progress, according to spokesperson Jenny Parker. Idaho in April became the 25th state to formally urge Congress to move on the issue.

Advertisement

“Fifty years of Supreme Court rulings mean voters don’t have a say over the rules,” she said. “Our solution is seeing very strong momentum, and it is across parties.”



Source link

Continue Reading

Maine

Searsmont fire official dies weeks after Maine lumber mill fire, explosion

Published

on

Searsmont fire official dies weeks after Maine lumber mill fire, explosion


Another person injured in the lumber mill fire and explosion in Searsmont, Maine, last month has died, officials said Sunday.

Wayne Woodbury, 76, died Sunday morning at Maine Medical Center, the Office of State Fire Marshal announced. He’d been part of the response to a May 15 fire at Robbins Lumber that led to a silo explosion. Another firefighter died, and a dozen people were hospitalized.

Woodbury was the town’s assistant fire chief. Chief James Ames was injured and later released.

“The Office of State Fire Marshal extends its sincere condolences to his family, friends, and the members of the Searsmont Fire Department during this difficult time,” the fire marshal’s office said in a statement.

Advertisement

Investigators have determined that the fire was accidental, but the investigation is ongoing.

Handout

Handout

Flames engulf a building at Robbins Lumber in Searsmont, Maine. A fire and explosion left at least one firefighter dead at the mill on Friday, May 15, 2026.

Maine State Fire Marshal

Maine State Fire Marshal

The fire and explosion caused a massive blaze that brought in firefighters from around the region. The firefighter who previously died was identified as 27-year-old Andrew Cross, of the Morrill Fire Department.

Mass General Hospital in Boston is treating two other patients from the mill. They were both listed as critical as of Saturday afternoon.



Source link

Advertisement
Continue Reading

Maine

Maine’s Dempsey Center shows the way on supportive cancer care | Opinion

Published

on

Maine’s Dempsey Center shows the way on supportive cancer care | Opinion


Sheri Biller is a cancer care advocate, philanthropist and the co-founder and president of The Sheri and Les Biller Family Foundation. Brandon Hotham is the president and CEO of the Dempsey Center.

Anyone who has faced cancer — or stood beside someone who has — knows that cancer is not just a medical condition. It is a life-altering experience that affects every part of a person’s world.

And yet, too often, patients and their caregivers are left to navigate that journey alone. That’s especially true in rural communities like many across Maine, where access to comprehensive support can be limited.

As a national cancer care advocate and as the leader of Maine’s Dempsey Center that provides cancer care services, we know it doesn’t have to be this way.

Advertisement

There is growing recognition of an approach to care called supportive cancer care — a model that focuses on treating the whole person, not just the disease. Supportive cancer care goes beyond clinical treatments like chemotherapy, radiation and surgery and includes a broad range of services such as financial guidance, counseling, pain and symptom management, caregiver support and help navigating practical challenges like transportation, insurance and goals-of-care conversations.

These services are delivered across both healthcare and community-based settings, often through a combination of providers and organizations working together to support patients and families throughout their cancer journey.

When these systems work well, the impact is clear. Access to supportive care improves quality of life and treatment adherence, reduces unnecessary emergency room visits and helps patients and families feel more confident navigating an incredibly complex experience. Just as importantly, it reinforces something deeply human: no one should have to face cancer alone.

Maine is helping show what’s possible in cancer care for the whole person.

The Dempsey Center is part of that broader network — providing community-based, evidence-informed supportive cancer care services that complement clinical treatment. We offer counseling, nutrition support, integrative therapies, movement and fitness programs and caregiver support, all designed to meet the evolving needs of individuals and families affected by cancer.

Advertisement

As a nonprofit organization, these services are provided at no cost to clients and are made possible entirely through philanthropy — through the generosity of donors, sponsors and community members who believe that everyone deserves access to this kind of care.

You can see the power of that community every year through the Dempsey Challenge, where thousands of participants — from Maine and around the world — come together to raise critical funds that sustain these services and ensure that no one faces cancer alone. As the need for these services continues to grow, so too does the importance of that support.

Maine is also making meaningful progress at the policy level. The state has taken important steps to support access to palliative care through MaineCare reimbursement, reinforcing that supportive care is not a luxury, but an essential part of high-quality cancer care. Initiatives like Maine’s specialty cancer license plates further invest in programs that provide patient support, fund research and expand access to care across the state.

Across Maine, a growing network of community-based supportive cancer care organizations — including members of the Association of Maine Cancer Support Centers — is working collectively to expand access to these services for as many Mainers as possible. And yet, despite this progress, access remains far from universal — both in Maine and across the country.

Nationally, only a fraction of patients can access supportive cancer care services like counseling, financial navigation or structured conversations about goals of care. Even when services exist, patients may not know to ask for them — or may assume they are not accessible or affordable. This leaves too many people and their loved ones carrying burdens they should not have to carry alone.

Advertisement

We need to continue building and strengthening these networks of care — across Maine and across the country. That means investing in community-based organizations, supporting policies that expand access and ensuring that patients and caregivers understand what supportive cancer care is and how to access it.

That’s also why the Dempsey Center is proud to support Support Is Care, a national campaign by The Sheri and Les Biller Family Foundation. It’s focused on helping people living with cancer and those who love them understand that this kind of support exists, that it’s part of high-quality care and that everyone has every right to ask their provider for it.

Last month, we gathered in our nation’s capital alongside providers, patients, caregivers and advocates from across our country — uplifting their voices, sharing their stories and advancing the case for supportive cancer care on Capitol Hill. We have to make sure that supportive cancer care is more widely understood, more consistently delivered and more equitably accessible.

Supportive cancer care isn’t “nice to have” — it’s a “must-have.” Research continues to show that when people have access to this kind of support, their outcomes and quality of life improve, and they experience fewer unnecessary visits to the emergency room.

Our work cannot stop there. We must all commit to building and sustaining the networks that make supportive cancer care accessible to everyone — regardless of where they live. That means continued investment in community-based programs, training providers and ensuring that every patient — regardless of ZIP code — knows what supportive cancer care is and feels empowered to ask for it.

Advertisement

No one should face cancer alone. Ask your providers about supportive cancer care. Advocate for systems that expand access. And consider how you can be part of the solution — whether by supporting community-based organizations or by showing up for those in your community who need help — because strength is built through connection, and connection starts with us.

Together, we can create a world where every patient and caregiver affected by cancer feels supported and heard.



Source link

Advertisement
Continue Reading
Advertisement

Trending